Modelos tumorais 2D e 3D para a avaliação de fármacos
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Tipo de documento: | Dissertação |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10400.6/9772 |
Resumo: | Drug combination emerged as a solution for the treatment of cancer, once this therapeutic approach allows to surpass the drug resistance of cancer cells and, simultaneously, eradicate the tumor. The assessment of drug-combination for pancreatic cancer treatment is usually performed in 2D cell cultures. However, these models are unable to mimic the drug resistance profiles found in pancreatic cancer. Thus, they may overestimate the therapeutic potential of the drug combination, leading to poor therapeutic performance in in vivo assays. Therefore, 3D culture models, especially spheroids, appear as a promising method for screening anticancer drugs, since they are able to mimic the structural and functional features of solid tumors. In the present study, the therapeutic effect and the synergistic potential of a particular combination of drugs in 2D and 3D cell cultures were analyzed and compared for the first time. In this way, the effect of the combination of Doxorubicin:Resveratrol (DOX:RES) (at molar ratios ranging from 5: 1 to 1: 5), in the viability of the pancreatic cancer cell line, PANC-1, was studied. The results showed that the viability of PANC-1 cells was more affected when the DOX:RES combinations contained a higher content of RES (molar ratios of 1:2 to 1:5). These results can be explained, by the ability of RES to reduce the efflux of DOX, mediated by P-glycoprotein (P-gp). Furthermore, these data also revealed that the synergistic effect of the DOX:RES combination was different in both 2D and 3D cell cultures. In fact, although 1:4 and 1:5 DOX: RES ratios were synergistic for these types of cell cultures, their values Combination Index (CI) were lower (more synergistic) in 2D cultures, when compared to spheroids. Overall, the results obtained revealed that the combination DOX:RES is promising approach for the treatment of pancreatic cancer and corroborate the need to perform drug screening. |
id |
RCAP_fbf74dc5eac14bb330c51b28b1195666 |
---|---|
oai_identifier_str |
oai:ubibliorum.ubi.pt:10400.6/9772 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Modelos tumorais 2D e 3D para a avaliação de fármacosCancro do PâncreasCulturas Celulares 2dDoxorrubicinaEsferóidesResveratrolDomínio/Área Científica::Ciências Médicas::Ciências BiomédicasDrug combination emerged as a solution for the treatment of cancer, once this therapeutic approach allows to surpass the drug resistance of cancer cells and, simultaneously, eradicate the tumor. The assessment of drug-combination for pancreatic cancer treatment is usually performed in 2D cell cultures. However, these models are unable to mimic the drug resistance profiles found in pancreatic cancer. Thus, they may overestimate the therapeutic potential of the drug combination, leading to poor therapeutic performance in in vivo assays. Therefore, 3D culture models, especially spheroids, appear as a promising method for screening anticancer drugs, since they are able to mimic the structural and functional features of solid tumors. In the present study, the therapeutic effect and the synergistic potential of a particular combination of drugs in 2D and 3D cell cultures were analyzed and compared for the first time. In this way, the effect of the combination of Doxorubicin:Resveratrol (DOX:RES) (at molar ratios ranging from 5: 1 to 1: 5), in the viability of the pancreatic cancer cell line, PANC-1, was studied. The results showed that the viability of PANC-1 cells was more affected when the DOX:RES combinations contained a higher content of RES (molar ratios of 1:2 to 1:5). These results can be explained, by the ability of RES to reduce the efflux of DOX, mediated by P-glycoprotein (P-gp). Furthermore, these data also revealed that the synergistic effect of the DOX:RES combination was different in both 2D and 3D cell cultures. In fact, although 1:4 and 1:5 DOX: RES ratios were synergistic for these types of cell cultures, their values Combination Index (CI) were lower (more synergistic) in 2D cultures, when compared to spheroids. Overall, the results obtained revealed that the combination DOX:RES is promising approach for the treatment of pancreatic cancer and corroborate the need to perform drug screening.A combinação de fármacos constitui uma abordagem terapêutica que tem sido usada no tratamento do cancro, uma vez que permite ultrapassar a resistência a fármacos das células cancerígenas e, simultaneamente, erradicar o tumor. A avaliação da combinação de fármacos é, habitualmente, realizada em modelos de cultura 2D. No entanto, estes modelos são incapazes de representar o perfil de resistência a fármacos que as células do cancro do pâncreas exibem. Deste modo, estes modelos podem sobrestimar o potencial terapêutico da combinação de fármacos, levando a um fraco desempenho terapêutico destes fármacos, nos ensaios in vivo. Recentemente, os modelos de cultura 3D, nomeadamente os esferóides, surgiram como plataformas promissoras para avaliação de combinação de fármacos anticancerígenos, uma vez que mimetizam eficazmente os mecanismos dos tumores in vivo. No presente estudo, analisou-se e comparou-se, pela primeira vez, o efeito terapêutico e o potencial sinergético da combinação de fármacos em culturas celulares 2D e 3D. Para tal, estudou-se o efeito da combinação de Doxorrubicina:Resveratrol (DOX:RES), com diferente rácios molares de 5:1 até 1:5, na viabilidade de células cancerígenas do pâncreas (PANC-1). Os resultados obtidos mostraram que a viabilidade das células PANC-1 foi mais afetada quando as combinações DOX:RES continham maior concentração de RES (rácios molares de 1:2 a 1:5). Estes resultados podem ser explicados pelo facto do RES ter capacidade de reduzir o efluxo da DOX para o exterior da célula, mediado pela glicoproteína-P (P-gp). Os dados revelaram também que o efeito sinérgico da combinação DOX:RES em culturas 2D e 3D foi diferente. De facto, apesar das proporções 1:4 e 1:5 DOX:RES apresentarem ambas um efeito sinérgico para os dois tipos de culturas, os seus valores de Índice de Combinação (CI) foram inferiores (mais sinérgicos) nas culturas 2D. Deste modo, os resultados obtidos revelaram que a combinação DOX:RES é uma abordagem promissora para o tratamento do cancro do pâncreas e corroboram a necessidade de avaliar a combinação de fármacos em culturas 3D.Correia, Ilídio Joaquim SobreiraCosta, Elisabete Cristina da RochauBibliorumBarros, Andreia Sofia de Sousa2021-06-20T00:30:15Z2018-07-202018-06-202018-07-20T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10400.6/9772TID:202353982enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-12-15T09:51:01Zoai:ubibliorum.ubi.pt:10400.6/9772Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T00:49:51.404437Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Modelos tumorais 2D e 3D para a avaliação de fármacos |
title |
Modelos tumorais 2D e 3D para a avaliação de fármacos |
spellingShingle |
Modelos tumorais 2D e 3D para a avaliação de fármacos Barros, Andreia Sofia de Sousa Cancro do Pâncreas Culturas Celulares 2d Doxorrubicina Esferóides Resveratrol Domínio/Área Científica::Ciências Médicas::Ciências Biomédicas |
title_short |
Modelos tumorais 2D e 3D para a avaliação de fármacos |
title_full |
Modelos tumorais 2D e 3D para a avaliação de fármacos |
title_fullStr |
Modelos tumorais 2D e 3D para a avaliação de fármacos |
title_full_unstemmed |
Modelos tumorais 2D e 3D para a avaliação de fármacos |
title_sort |
Modelos tumorais 2D e 3D para a avaliação de fármacos |
author |
Barros, Andreia Sofia de Sousa |
author_facet |
Barros, Andreia Sofia de Sousa |
author_role |
author |
dc.contributor.none.fl_str_mv |
Correia, Ilídio Joaquim Sobreira Costa, Elisabete Cristina da Rocha uBibliorum |
dc.contributor.author.fl_str_mv |
Barros, Andreia Sofia de Sousa |
dc.subject.por.fl_str_mv |
Cancro do Pâncreas Culturas Celulares 2d Doxorrubicina Esferóides Resveratrol Domínio/Área Científica::Ciências Médicas::Ciências Biomédicas |
topic |
Cancro do Pâncreas Culturas Celulares 2d Doxorrubicina Esferóides Resveratrol Domínio/Área Científica::Ciências Médicas::Ciências Biomédicas |
description |
Drug combination emerged as a solution for the treatment of cancer, once this therapeutic approach allows to surpass the drug resistance of cancer cells and, simultaneously, eradicate the tumor. The assessment of drug-combination for pancreatic cancer treatment is usually performed in 2D cell cultures. However, these models are unable to mimic the drug resistance profiles found in pancreatic cancer. Thus, they may overestimate the therapeutic potential of the drug combination, leading to poor therapeutic performance in in vivo assays. Therefore, 3D culture models, especially spheroids, appear as a promising method for screening anticancer drugs, since they are able to mimic the structural and functional features of solid tumors. In the present study, the therapeutic effect and the synergistic potential of a particular combination of drugs in 2D and 3D cell cultures were analyzed and compared for the first time. In this way, the effect of the combination of Doxorubicin:Resveratrol (DOX:RES) (at molar ratios ranging from 5: 1 to 1: 5), in the viability of the pancreatic cancer cell line, PANC-1, was studied. The results showed that the viability of PANC-1 cells was more affected when the DOX:RES combinations contained a higher content of RES (molar ratios of 1:2 to 1:5). These results can be explained, by the ability of RES to reduce the efflux of DOX, mediated by P-glycoprotein (P-gp). Furthermore, these data also revealed that the synergistic effect of the DOX:RES combination was different in both 2D and 3D cell cultures. In fact, although 1:4 and 1:5 DOX: RES ratios were synergistic for these types of cell cultures, their values Combination Index (CI) were lower (more synergistic) in 2D cultures, when compared to spheroids. Overall, the results obtained revealed that the combination DOX:RES is promising approach for the treatment of pancreatic cancer and corroborate the need to perform drug screening. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-07-20 2018-06-20 2018-07-20T00:00:00Z 2021-06-20T00:30:15Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.6/9772 TID:202353982 |
url |
http://hdl.handle.net/10400.6/9772 |
identifier_str_mv |
TID:202353982 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799136389706547200 |